Preliminary reports reveal conolidine may well inhibit specific ion channels, lowering neuronal excitability and restricting soreness indicators. This mechanism is particularly applicable in neuropathic soreness, where abnormal signaling results in persistent soreness. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathw